Sanrio ¥135.1 billion secondary offering
The shares are listed on the Tokyo Stock Exchange
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
Banco Santander $2 billion notes offering
We advised Banco Santander on the offering
Banco Santander $3.5 billion cash tender offers
We advised Banco Santander on its tender offers for fixed-rate notes
Rakuten Group $550 million subordinated notes offering
The 8.125% reset notes are listed on the Singapore Exchange
ASMedia Technology $390 million acquisition of Techpoint
We are advising ASMedia on the transaction
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
CRH $3 billion guaranteed notes offering
The investment-grade notes are due 2030, 2035 and 2055
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing